The scheduling of these trials means those who believe they have been injured by transvaginal mesh are one step closer to the possibility of being made whole.
New York, NY (PRWEB) December 18, 2012
Trials of transvaginal mesh lawsuits against three major mesh manufacturers will begin Dec. 3, 2013, in the U.S. District Court for the Southern District of West Virginia, according to a report detailing the decisions made at a Dec. 6 status conference.
The report shows that the West Virginia federal court scheduled as the first trial one of the cases consolidated in In re: American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2325). This will be followed by trials of cases in In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2327) and In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (MDL No. 2326).
Trial of a case consolidated in In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2187), will begin February 2013, according to the status conference report. U.S. District Judge Joseph R. Goodwin is overseeing all six federal transvaginal mesh multidistrict litigation matters.
“The scheduling of these trials means those who believe they have been injured by their transvaginal mesh surgeries are one step closer to the possibility of being made whole again,” said Rochelle Rottenstein, principal of the Rottenstein Law Group, which represents transvaginal mesh patients nationally.
Since 2011, the U.S. Food and Drug Administration has received reports of problems associated with transvaginal mesh used to treat pelvic organ prolapse stress urinary incontinence. Serious complications associated with the use of transvaginal mesh are not rare, according to the FDA. Some serious side effects include bleeding, urinary problems, pain and infection.
The ProteGen Sling was voluntarily recalled in 1999 by its manufacturer, Boston Scientific, after that company received thousands of complaints regarding the transvaginal mesh product, according to a July 1, 2002, article in U.S. News and World Report. Another surgical mesh product, a vaginal sling known as ObTape, was discontinued in 2006 by its manufacturer, Mentor Corporation, which was eventually acquired by Johnson & Johnson, according to a May 4, 2009, piece in the New York Times.
There are still a number of mesh products on the market, though. Doctors are still using the Avaulta System and the Johnson & Johnson surgical mesh product known as Gynecare TVT is still in use, despite its FDA approval based on its similarity to Boston Scientific’s ProteGen Sling, according to Bloomberg.
The Rottenstein Law Group maintains a website at http://www.bladdermeshlawsuitcenter.com with a wealth of information regarding mesh lawsuits and side effects. Women who believe they are suffering from serious side effects related to their mesh surgery should contact Rottenstein Law Group today for a free consultation.
About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices.
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com